Imricor Medical Systems
Logotype for Imricor Medical Systems Inc

Imricor Medical Systems (IMR) investor relations material

Imricor Medical Systems H2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Imricor Medical Systems Inc
H2 2025 earnings summary24 Feb, 2026

Executive summary

  • Achieved CE Mark approval for second-generation ablation catheter, NorthStar MRI-native 3D mapping system, and capital equipment in Europe under EU MDR.

  • Performed world-first in vivo PFA ablations and first-in-human ischemic VT ablation under real-time MRI guidance, validating the technology and field.

  • Expanded clinical trial footprint in the US and Europe, with new hospital sites, regulatory submissions, and VISABL-AFL trial expansion.

  • Commercial readiness advanced with Philips MRI platform integration, European sales team expansion, and customer pipeline growth from 7 to 40 sites.

  • Strengthened leadership and board to support commercialization and growth.

Financial highlights

  • FY 2025 revenue was $292,000, down from $959,000 year-over-year, mainly due to non-revenue-generating clinical trial procedures.

  • Consumable device sales fell 63% to $171,000; equipment revenues also declined.

  • Operating cash outflow was $19 million, up $3.5 million from the prior year, reflecting increased investment in commercial and regulatory activities.

  • Net loss before tax was $25.3 million, a 15% improvement from the prior year, but adjusted net loss rose 33% to $20.99 million.

  • Cash and marketable securities totaled $40.8 million at year-end.

Outlook and guidance

  • Positioned to scale commercially in Europe, Middle East, and soon the U.S. as regulatory approvals progress.

  • Anticipates FDA approval for U.S. commercial release of platform technology and further 510(k) submissions in the next 3–6 months.

  • Expects acceleration in consumable revenues and capital sales as clinical trial sites convert to commercial use.

  • New site activations expected in the US, ANZ, Nordics, and Middle East within 6–12 months.

  • VISABL-AFL trial completion and platform approval targeted for this calendar year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Imricor Medical Systems earnings date

Logotype for Imricor Medical Systems Inc
Q1 202628 Apr, 2026
Imricor Medical Systems
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Imricor Medical Systems earnings date

Logotype for Imricor Medical Systems Inc
Q1 202628 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Imricor Medical Systems Inc. specializes in the development of innovative MRI-compatible medical devices for MRI-guided cardiac catheter ablation procedures. Their products aim to enhance the success rates and reduce the overall costs of these procedures. Key products from Imricor include the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator, both designed for use under real-time MRI guidance to offer a safer, faster, and more effective treatment compared to traditional x-ray guided catheter ablation methods. Imricor Medical Systems Inc. is headquartered in Burnsville, Minnesota, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage